Choosing the right provider is just as important as choosing the right medication. A reliable Wegovy comparison site should help you compare more than just prices. It should also give you clear information about dose availability, prescribing standards, delivery, and ongoing treatment support. At EverydayMeds, we make it easier to compare Wegovy by offering all licensed doses in one place, transparent pricing with no hidden fees, and a clinically supervised prescribing process from start to finish.
Whether you are starting treatment with the 0.25 mg dose or progressing to the 2.4 mg maintenance dose, our pharmacy aims to keep stock available across the full licensed Wegovy dose range, subject to availability. This may help reduce the need to change providers during treatment if a particular dose strength is unavailable elsewhere. All medicines are licensed, sourced through authorised UK wholesalers, and supplied following an individual assessment by qualified prescribers through a regulated prescribing service.
Compare Every Licensed Wegovy Dose in One Place
Successful weight management depends on following the recommended dose-escalation schedule without interruption. EverydayMeds keeps all five licensed Wegovy strengths available, making it easier to continue treatment exactly as prescribed.
| Wegovy Dose | Typical Treatment Stage |
|---|---|
| 0.25mg | Weeks 1–4 |
| 0.5mg | Weeks 5–8 |
| 1mg | Weeks 9–12 |
| 1.7mg | Weeks 13–16 |
| 2.4mg | Week 17 onwards (maintenance) |
Maintaining access to every licensed dose may help support continuity of treatment and reduce the need to change providers during dose escalation .
Transparent Wegovy Pricing Across the Full Range
Comparing Wegovy providers is not just about finding the lowest advertised price. To compare the overall Wegovy cost fairly, it is important to consider the total cost at checkout, including consultation fees, prescription charges, and administration fees, rather than focusing only on the headline price. EverydayMeds keeps pricing straightforward by clearly showing the cost of each licensed dose, helping you understand what you may pay throughout your treatment.
In the UK, private Wegovy prescriptions commonly range from around £80 to £299 per month, depending on the prescribed dose and the provider.
Patients can also choose from treatment bundles designed to support dose progression while comparing monthly costs, subscription options, and one off purchases. Wegovy 0.25 mg is often available from around £80 to £99 after discounts, depending on the provider and any offers available. New customers can apply the code FIRST40 at checkout, while returning customers can use DOSE25, subject to the applicable offer terms.
What Makes a Good Wegovy Comparison Site?
Not every comparison page provides the information patients need before starting treatment. A useful Wegovy price comparison should help you compare the complete service, not just the price of the medication.
When comparing providers, consider:
- Availability of all five licensed Wegovy doses.
- Transparent pricing with no hidden fees.
- Qualified UK prescriber review.
- GPhC registered pharmacy.
- Genuine Novo Nordisk medicines.
- Next day cold chain delivery.
- Ongoing support throughout dose escalation.
- Flexible bundle options to help support uninterrupted treatment.
Prices may vary between high street and online pharmacies depending on the provider and the services included.
Considering these factors can help you compare the overall value of each provider, rather than focusing only on the headline price.
Why Patients Compare Wegovy with EverydayMeds
EverydayMeds is a GPhC registered online pharmacy with an online doctor led prescribing process, combining regulated pharmacy services with a patient focused experience designed to make the prescribing process straightforward. From your initial online clinical assessment through to delivery, every stage of the process is managed with safety, transparency, and convenience in mind.
Our service includes:
- Complete availability of every licensed Wegovy strength, subject to stock availability.
- Online clinical assessment.
- Express 24 hour prescriber review available where applicable.
- Temperature controlled next day delivery after prescription approval.
- Transparent pricing across all licensed doses and bundle options.
Ongoing access to prescription support throughout your treatment, with appropriate monitoring and patient safety as part of our regulated prescribing service.
Whether you are comparing providers for the first time or looking for a pharmacy that can support your treatment over the long term, EverydayMeds provides a regulated UK prescribing service for eligible patients who may be suitable for licensed Wegovy following a clinical assessment.
How Wegovy Supports Weight Loss and Management
How does Wegovy work?
Wegovy contains semaglutide, which mimics the naturally occurring GLP 1 hormone and may help reduce hunger while increasing feelings of fullness. After a once weekly injection, semaglutide acts on areas of the brain involved in regulating hunger and fullness. This may help some patients feel satisfied after eating smaller portions while reducing food cravings. It may also slow gastric emptying, allowing food to remain in the stomach for longer, which may contribute to prolonged feelings of fullness.
Rather than acting as a stimulant or "fat burner", Wegovy is a prescription medicine licensed in the UK for chronic weight management in eligible patients when used alongside lifestyle changes. It may support weight management by helping some people reduce their calorie intake when combined with a reduced calorie diet and regular physical activity. To help improve tolerability, treatment follows a gradual dose escalation schedule over 16 weeks before reaching the recommended maintenance dose of 2.4 mg. Wegovy (semaglutide) is licensed by the MHRA for chronic weight management in eligible patients in the UK and is also approved by the FDA in the United States for long term weight management.
Clinical Evidence Behind Wegovy
Wegovy's approval for weight management is supported by the internationally recognised STEP clinical trial programme, which evaluated semaglutide in thousands of adults living with overweight or obesity.
The landmark STEP 1 study, published by Wilding et al. in the *New England Journal of Medicine* (2021), found that participants receiving Wegovy alongside lifestyle changes achieved an average weight loss of approximately 15% over 68 weeks, compared with 2.4% in the placebo group. Individual responses vary, and weight loss may become more noticeable over time as treatment progresses through the recommended dose escalation schedule.
Further studies expanded this evidence:
STEP 2 evaluated adults with type 2 diabetes.
STEP 3 evaluated Wegovy alongside intensive behavioural therapy.
STEP 5 demonstrated sustained weight management during two years of continued treatment.
The SELECT cardiovascular outcomes trial also reported a reduction in major adverse cardiovascular events in eligible patients with established cardiovascular disease.
Common side effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain. The frequency of these side effects varies between clinical studies and individuals. Many gastrointestinal side effects improve as treatment continues, although experiences vary between individuals.
Serious side effects can include pancreatitis, kidney problems, and a warning about the potential risk of thyroid C cell tumours identified in animal studies. This is one of the reasons treatment should be supervised by a qualified healthcare professional.
Individual results vary, and Wegovy should always be used under the supervision of a qualified healthcare professional alongside healthy lifestyle changes.
Wegovy vs Mounjaro: A Practical Comparison
Many patients researching weight management treatments compare Wegovy with Mounjaro. While both medicines are administered once weekly and require a prescription, Wegovy contains semaglutide and Mounjaro contains tirzepatide, and they differ in their mechanisms of action and treatment pathways.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Drug class | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist |
| Injection frequency | Once weekly | Once weekly |
| Dose escalation | 5 licensed strengths | 6 licensed strengths |
| Room-temperature storage | Up to 6 weeks | Approximately 21 days |
| UK availability | Prescription only | Prescription only |
In separate clinical trials, participants receiving Mounjaro achieved average weight loss of around 20 to 22%, while participants receiving Wegovy achieved average weight loss of around 15 to 17%. However, these results came from separate clinical trial programmes and should not be interpreted as direct comparisons because the study designs and participant groups differed.
Individual responses vary, and treatment suitability should be determined through a clinical assessment rather than expected weight loss outcomes alone. Dual GLP 1 and GIP receptor agonists, such as tirzepatide, have demonstrated greater average weight loss in separate clinical trials, although these findings should be interpreted with caution because they are not based on direct head to head comparisons.
The most suitable treatment depends on factors such as your medical history, BMI, previous treatment experience, and a clinical assessment. Wegovy is licensed in the UK for chronic weight management in eligible patients, while Ozempic is licensed for the treatment of type 2 diabetes under a different indication and has a lower maximum licensed dose than Wegovy.
Storage and Everyday Convenience
When comparing weight management injections, storage flexibility can be an important consideration, particularly for people who travel frequently or have busy schedules.
Before first use, Wegovy should be stored in a refrigerator between 2°C and 8°C. Once removed from the refrigerator, it can be stored at room temperature below 30°C for up to six weeks, in line with the manufacturer's instructions. This may offer greater flexibility for some patients compared with medicines that have shorter permitted room temperature storage periods.
Each Wegovy FlexTouch pen is prefilled and designed for once weekly administration. The recommended injection sites include:
- Abdomen.
- Thigh.
- Upper arm.
Rotating injection sites each week may help reduce the risk of local skin irritation and support consistent absorption of the medicine.
Why Continuous Stock Availability Matters
Weight management with Wegovy follows a carefully planned dose escalation schedule, so having access to the correct dose at the right time is important. If a required strength is unavailable, treatment progression may be delayed, which could affect continuity of treatment.
EverydayMeds aims to maintain availability across the full licensed Wegovy dose range, subject to stock availability. This helps eligible patients continue through the recommended dose escalation schedule without needing to change providers.
Our stock management approach includes:
- All five licensed Wegovy strengths, subject to stock availability.
- Convenient treatment bundles.
- Reliable UK supply through authorised wholesalers.
- Temperature controlled cold chain delivery.
- Express prescription review options where applicable.
This may help reduce the need to search multiple pharmacies during dose escalation.
Comparing More Than Just Price: Finding the Cheapest Wegovy Provider
While cost is an important consideration, choosing a provider based only on the lowest price may overlook other factors that contribute to a safe and reliable prescribing experience.
When comparing Wegovy prices, remember that costs can vary depending on the prescribed dose, provider, delivery service, and the level of support included. It is worth considering:
- Medicine authenticity.
- GPhC registration.
- Clinical assessment standards.
- Prescription turnaround times.
- Cold chain delivery.
- Ongoing patient support.
- Availability of all licensed Wegovy doses.
- Transparent pricing with no hidden charges.
Looking at the complete service, not just the price, can help you choose a provider that best meets your needs throughout your treatment journey.
The total monthly cost may include consultation fees, prescription fees, delivery charges, and follow up support, as well as the cost of the medication.
Why Choose EverydayMeds for Wegovy?
Finding a pharmacy that offers licensed Wegovy is only part of the decision. When NHS access is limited, many patients choose private Wegovy prescriptions to access treatment. The quality of clinical support, medicine availability, and delivery standards can all contribute to a positive treatment experience. EverydayMeds combines regulated pharmacy services with a straightforward online prescribing process, helping eligible patients access treatment following a clinical assessment and prescription approval.
Our team aims to provide ongoing support throughout your weight management journey, not just with your first order. As a UK provider offering specialist weight management services, we focus on transparent pricing, subject to stock availability, and regulated clinical support from your initial assessment through to repeat prescriptions, where appropriate.
What You Can Expect
- All five licensed Wegovy doses available
- GPhC-registered UK pharmacy (\#9012878)
- Qualified prescriber review for every order
- Express 24-hour review option available
- Genuine Novo Nordisk Wegovy sourced through authorised UK wholesalers
- Temperature-controlled next-day delivery after prescription approval
- Transparent pricing with no hidden consultation fees
- Bundle options to help support continuity of treatment
- Ongoing prescription and customer support for safely dispensing Wegovy through a regulated UK pharmacy
Your Wegovy Journey in Four Simple Steps
Starting treatment through EverydayMeds is designed to be quick, secure, and fully compliant with UK prescribing regulations.
1. Complete Your Online Assessment
Begin with our secure clinical questionnaire, which takes approximately three minutes to complete. Your answers help our prescribers assess whether Wegovy is appropriate for your individual circumstances, including BMI, related health conditions such as high blood pressure, and whether NHS or private access is more appropriate. NHS eligibility criteria vary depending on local commissioning arrangements and current NICE guidance , although access pathways can differ.
2. Clinical Review
A qualified UK prescriber reviews your online clinical assessment, medical history, current medications, and treatment goals. Standard reviews are completed within 3 working days, with an express 24 hour review available for eligible orders where applicable. Treatment is only prescribed following approval by a qualified prescriber, and any dose change or restart also requires a new clinical review and prescriber approval.
3. Prescription Approval
If Wegovy is clinically suitable, your prescription may be approved and prepared by our GPhC registered pharmacy using genuine licensed medicines sourced through authorised UK pharmaceutical wholesalers. Buying Wegovy online legally requires a valid prescription from an appropriately qualified prescriber and supply through a regulated pharmacy in line with General Pharmaceutical Council (GPhC) standards.
4. Cold-Chain Delivery
Your order is dispatched using temperature controlled packaging designed to help maintain the recommended storage temperature of 2°C to 8°C during transit. Delivery is arranged using a service suitable for temperature sensitive medicines. Delivery charges may vary between providers and can affect the total cost when comparing treatment options, even where delivery standards are similar.
